AAV-GFP-iCre (AAV2) AAV (AAV2-GFP-iCre)

Cre recombinase is used as a tool to genetically modify genes, such as to delete a segment of DNA flanked by LoxP sites in cells or experimental animals.By applying the mammalian codon usage to Cre recombinase, expression of Cre is improved in the mammalian cells. This improved Cre (iCre) gene also reduce the high CpG content of the prokaryotic coding sequence, thereby reducing the chances of epigenetic silencing in mammals.This AAV2 stock expresses an improved Cre (iCre) along with an eGFP under a control of the same CMV promoter. The Cre and eGFP was separated by a 2A peptides.

AAV-GFP-iCre (AAV2) AAV

41106621

3822190000

Pre-Made

Dry Ice

-80C

12 Months

AAV2-GFP-iCre

AAV2

AAV2

Recombinant AAV

CMV (ubiquitous)

EGFP

PBS/5% Glycerol

1x10^13 GC/ml